Search details
1.
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Lancet
; 403(10427): 632-644, 2024 Feb 17.
Article
in English
| MEDLINE | ID: mdl-38246194
2.
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.
J Natl Compr Canc Netw
; 22(1D): e240002, 2024 01.
Article
in English
| MEDLINE | ID: mdl-38244274
3.
Radiation and Melanoma: Where Are We Now?
Curr Oncol Rep
; 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38822928
4.
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(11): 1181-1203, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37935106
5.
Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.
Ann Surg Oncol
; 29(2): 806-815, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34537899
6.
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(4): 387-405, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35390769
7.
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.
J Natl Compr Canc Netw
; 19(12): 1382-1394, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34902824
8.
Frequency and implications of occipital and posterior auricular sentinel lymph nodes in scalp melanoma.
J Surg Oncol
; 120(8): 1470-1475, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31614003
9.
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
J Surg Oncol
; 120(7): 1276-1283, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31602665
10.
PD-1 inhibitor induced alopecia areata.
Dermatol Online J
; 24(12)2018 Dec 15.
Article
in English
| MEDLINE | ID: mdl-30677804
11.
Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors.
Hum Vaccin Immunother
; 19(1): 2207438, 2023 12 31.
Article
in English
| MEDLINE | ID: mdl-37157982
12.
Phase 1b study of cobimetinib plus atezolizumab in patients with advanced BRAFV600 wild-type melanoma progressing on prior anti-programmed death-1 therapy.
Eur J Cancer
; 178: 180-190, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36455412
13.
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies.
Clin Cancer Res
; 29(13): 2435-2444, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37227176
14.
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.
Clin Cancer Res
; 29(7): 1209-1219, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36378549
15.
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.
Cancer Chemother Pharmacol
; 92(1): 15-28, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37219686
16.
Circulating CD8+ mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients.
Clin Transl Immunology
; 11(1): e1367, 2022.
Article
in English
| MEDLINE | ID: mdl-35028137
17.
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study.
J Immunother Cancer
; 10(12)2022 12.
Article
in English
| MEDLINE | ID: mdl-36600653
18.
Practical cardiovascular imaging approach to diagnose immune checkpoint inhibitor myocarditis.
Eur Heart J Cardiovasc Imaging
; 22(4): 372-374, 2021 03 22.
Article
in English
| MEDLINE | ID: mdl-33367684
19.
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.
Cancer Discov
; 11(12): 2998-3007, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34326162
20.
Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse Xenograft.
Mol Cancer Res
; 19(2): 346-357, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33087417